Broncholytin NEO syrup 110 ml.

COMPOSITION
Drugs : Glaucine hydrobromide 5.75 mg, Pseudoephedrine hydrochloride 5 mg in 5 ml syrup.
Excipients : sucrose , ethanol ( 96%) , methylparahydroxybenzoate propylparahydroxybenzoate , basil oil , citric acid monohydrate , polysorbate 80, purified water.
 

 
ACTION Bronholitin NEO is a combined product with expressed antitussive and bronchodilator action.
Alkaloid Glaucine suppresses the cough center without affecting breathing. Slightly expands the bronchi by improving their road . Enhances the secretion of bronchial secretions . Does not cause tolerance and addiction.
Pseudoephedrine constricts blood vessels in the bronchial tubes , thereby reducing the swelling and venous stasis in the bronchial mucosa . A weak stimulating effect on the CNS .
 
 cough in acute and chronic bronchitis, tracheobronchitis , asthmatic bronchitis , bronchial asthma and whooping cough .
 
To any component of the product. Due to the presence of pseudoephedrine in the composition Broncholytin NEO should not be taken in: patients with high blood pressure , severe organic disease with cardiac decompensation phenomena , angina , atherosclerosis ; insomnia ; thyrotoxicosis ; pheochromocytoma ; narrow-angle glaucoma ; prostatic adenoma with urinary retention ; therapy with MAO inhibitors; children under 4 years vazrast.PREDPAZNI precautions Warning
PRECAUTIONS
For diabetics ! 5 ml of syrup contains 2 g of sugar .
When taken according to according to the dosage recommendations each dose (15 ml) provide up to 6 dosage recommendations each dose (15 ml) provide up to 6 g of sucrose ( 25 kcal. ) . Broncholytin NEO is unsuitable for people with hereditary fructose intolerance , malabsorption to sugars or sucrose - isomaltase insufficiency. This product contains 1.78 % by volume of ethanol. A danger for those suffering from liver disease , alcoholism, epilepsy, brain injury or disease , as well as pregnant women and children . You can change or enhance the effects of other drugs.
Be administered with caution to a combination of bronchodilators and Broncholytin NEO in patients with asthma due to the efforts of some side effects - tremors , palpitations , agitation , abnormal heart rhythm , arterial hypertension.
 
Interactions
With concomitant Broncholytin NEO with guanethidine antagonize the action of guanethidine . MAO inhibitors and beta- adrenergic blocking agents may enhance the effect of pseudoephedrine . Use in pregnancy and lactation
Do not apply during the first three months of pregnancy and during lactation .
Do not use in children under 4 years of age.
Effects on ability to drive and use an impact driver .
 
APPLICATION AND DOZIROVKAAko doctor advises otherwise , the dose in adults and children over 10 years is 15 ml ( 1 tablespoon ) 3-4 times daily ; in children 4 to 10 years is 5 ml ( 1 teaspoon) 3 times daily.
 
PREDOZIRANEPri overdose can occur nausea, vomiting, loss of appetite , nervous agitation, trembling of limbs , dizziness, difficulty urinating . If for any reason the patient took more than the prescribed dose of the product is required to immediately inform the doctor.
 
SIDE REACTION  may experience transient slight tremor and palpitations that occurred 15-30 minutes after taking the syrup.
Due to parahydroxybenzoates in the composition of the syrup are possible hypersensitivity reactions (urticaria , dermatitis, bronchospasm) . In patients with prostatic hypertrophy, can be observed urinary retention. Diseases of the cardiovascular system are possible rhythm and conduction disorders , arterial hypertension.
 
Storage dry place below 25 ° C. Keep out of reach of children!
SHELF GODNOST3 godiniDa not use after the expiry date stated on the package !